AOM Infusion
AOM Infusion is a Fort Worth, Texas-based specialty infusion pharmacy that delivers IVIG, SCIG, biologic, and chronic inflammatory infusion therapies to patients with 80+ chronic conditions across all 50 U.S. states, serving through home infusion and ambulatory infusion suites under Revelstoke Capital Partners ownership.
- Company typePrivate
- Founded1995
- HeadquartersFort Worth, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What AOM Infusion does
AOM Infusion is a privately held, U.S. specialty infusion pharmacy provider headquartered in Fort Worth, Texas, founded in 1994-1995 (sources vary) and operating under healthcare-services investor Revelstoke Capital Partners since April 2025. The company delivers intravenous immunoglobulin (IVIG), subcutaneous immunoglobulin (SCIG), chronic inflammatory and biologic infusions, and a set of specialized therapies (including infertility treatments) to patients with over 80 chronic conditions spanning neurological, immunological, and inflammatory diseases. Services are delivered through two modalities: a national home infusion operation (with nursing, pharmacy dispensing, and 24/7 clinical support) and a small but growing network of ambulatory infusion suites, currently operating in Brooklyn, NY and Arlington, TX, with additional sites planned.
AOM's core technology stack consists of a connected care platform that transmits patient clinical data, assessments, and lab results back to prescribers, paired with a Clinical Care Navigator Program of registered nurse coordinators who perform risk assessments, monitor therapy response, and maintain between-treatment contact. The company holds ACHC Specialty Pharmacy and Infusion Pharmacy Accreditations and, in March 2026, became one of the first providers nationwide to receive the ACHC Distinction in Immunoglobulin (Ig) Therapy issued in collaboration with the Immunoglobulin National Society (IgNS). It is licensed as a pharmacy in all 50 states and dispenses an 18-product branded IVIG portfolio that includes limited distribution products such as Kedrion Biopharma's QIVIGY and YIMMUGO.
Revenue is generated primarily from fee-for-service dispensing of high-cost specialty biologics and infusion administration, billed to insurance payors including Medicare Part D, commercial health plans, managed care organizations, TPAs, PPOs, and self-insured plans. Go-to-market is a hybrid B2B/B2C model: B2B referral relationships with physicians, neurologists, immunologists, rheumatologists, and health systems (with a one-hour referral response commitment) drive patient acquisition, while B2C engagement occurs through direct patient outreach, an educational content library, and a dedicated insurance verification and prior authorization team. Strategic enterprise partnerships extend to pharmaceutical manufacturers for limited distribution access and to insurance providers for network participation and seamless care coordination.
AOM Infusion firmographics
Firmographics- Name
- AOM Infusion
- Legal name
- AOM Infusion
- Website
- https://aominfusionrx.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- AOM Infusion is a Fort Worth, Texas-based specialty infusion pharmacy that delivers IVIG, SCIG, biologic, and chronic inflammatory infusion therapies to patients with 80+ chronic conditions across all 50 U.S. states, serving through home infusion and ambulatory infusion suites under Revelstoke Capital Partners ownership.
- Ownership category
- akta.pro rank
AOM Infusion industry classification
Industry- Product category
- Specialty Infusion Pharmacy
- NAICS
- All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Home Infusion Therapy & IV Nursing Services (HLADAFAG), Infusion Therapy Centers (Outpatient) (HLAFABAF), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)
Keywords
Where AOM Infusion is headquartered
LocationHeadquarters
- HQ city
- Fort Worth
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
AOM Infusion business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Specialty Infusion Therapy Services: Revenue generated from providing infusion therapy services including IVIG, SCIG, chronic inflammatory & biologic infusions to patients with chronic conditions. Services are billed to insurance payors including Medicare Part D, commercial payors, and self-insured plans.
- Specialty Pharmacy Dispensing: Dispensing of all medications, solutions and supplies as ordered by prescribing physicians. Revenue from medication dispensing, delivery services, and ancillary supplies (syringes, needles, alcohol swabs).
- Copay Assistance & Financial Support Services: Patient advocacy services including copay assistance programs, insurance verification, pre-certification and authorization services. Revenue derived from administrative services and manufacturer support programs.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
AOM Infusion product offering
Product offeringCore offering
AOM Infusion is a specialty infusion pharmacy that administers infusion therapies—primarily intravenous and subcutaneous immunoglobulin (IVIG/SCIG), chronic inflammatory and biologic infusions, and specialized therapies—to patients with chronic neurologic, immunologic, and inflammatory conditions. Services are delivered either in the patient's home or in state-of-the-art ambulatory infusion suites in Brooklyn, NY and Arlington, TX, supported by insurance verification, prior authorization, and a Clinical Care Navigator Program for care coordination.
Product overview
AOM Infusion is a specialty infusion pharmacy provider offering a comprehensive portfolio of infusion therapy services for over 80 chronic conditions. The company's core offerings include Immunoglobulin (IVIG) Therapy and Subcutaneous Immunoglobulin (SCIG) Therapy as primary treatments, supplemented by Chronic Inflammatory & Biologic Infusions (including infliximab, entyvio, stelara) and Specialized Therapies (such as Nulogix, Actemra, Orencia). Services are delivered through two modalities: Home Infusion Services with nurse administration and 24/7 clinical support, and AOM Infusion Suites (ambulatory infusion centers) in Brooklyn, NY and Arlington, TX. The company maintains a broad IVIG medication portfolio encompassing 18+ branded products including Qivigy and Yimmugo. A Clinical Care Navigator Program provides registered nurse-led care coordination throughout the treatment journey.
Differentiator
Problem solved
Functional benefit
Products and services
- Immunoglobulin (IVIG) Therapy Intravenous immunoglobulin replacement therapy administered directly into the bloodstream, typically every three to four weeks, for patients with primary immunodeficiencies and autoimmune disorders.
- Subcutaneous Immunoglobulin (SCIG) Therapy Subcutaneous immunoglobulin therapy delivered just under the skin in smaller, more frequent doses, allowing self-administration at home after nurse-led training.
- Chronic Inflammatory & Biologic Infusions Infusion therapies including infliximab, Entyvio, Stelara, and other biologics for chronic inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and ulcerative colitis.
- Specialized Therapies Specialized infusion treatments including Nulogix, Actemra, Orencia, and infertility therapies for complex conditions.
- AOM Infusion Suites State-of-the-art ambulatory infusion centers offering private treatment rooms as an alternative to hospital-based infusion care, located in Brooklyn, NY and Arlington, TX.
- Home Infusion Services At-home infusion therapy delivery with nurse administration, medication coordination, and 24/7 clinical support for patients unable to travel to infusion centers.
- Clinical Care Navigator Program Registered nurse-led care coordination program overseeing patient risk assessments, therapy response monitoring, and between-treatment follow-up throughout the treatment journey.
Companies that use AOM Infusion
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
AOM Infusion technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
AOM Infusion partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Kedrion BiopharmacoreAOM Infusion was selected as a limited distribution specialty pharmacy for Kedrion's QIVIGY® immune globulin therapy. This expands AOM's portfolio of immune therapy products and follows AOM's recognition for clinical excellence and inclusion in Kedrion's limited distribution network. AOM is also a designated limited distribution partner for YIMMUGO® immunoglobulin replacement therapy.
- Major Insurance CarrierscoreAOM Infusion is a participating provider with most major insurance carriers and has active contracts with a variety of commercial payors including traditional health plans, managed care organizations, PPOs, TPAs, self-insured plans, and provider network managers.
- Pharmaceutical ManufacturerscoreAOM collaborates with pharmaceutical manufacturers to provide the most effective specialty infusion care. Their clinical and procurement team stays ahead of the curve with IVIG products and manufacturer relationships. AOM receives priority access to IVIG products from at least one specialty pharmacy distributor due to their clinical expertise and patient-centric approach.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
AOM Infusion competitors and assessment
Company assessmentDirect peers
- Option Care Health: Option Care Health is the largest independent provider of home and alternate-site infusion services in the U.S., offering IVIG, biologics, and chronic-condition infusion therapy. It is the most directly comparable peer to AOM Infusion, operating a similar hybrid home-and-suite delivery model for the same immunoglobulin and biologic franchises.
- Coram CVS Specialty Infusion Services: Coram, a CVS Health company, is one of the largest U.S. providers of home infusion and specialty pharmacy services, including IVIG/SCIG and biologic therapies. It directly competes with AOM across payor contracts, hospital-to-home diversion, and physician referral networks.
- Soleo Health: Soleo Health is a specialty infusion services company providing home and alternate-site infusion therapies including immunoglobulin, biologics, and anti-infectives. It operates in the same IVIG-heavy ambulatory market as AOM and is a frequent competitor in physician-referral channels.
- KabaFusion: KabaFusion is a national home infusion company specializing in IVIG, SCIg, and other specialty infusion therapies for chronic conditions such as CIDP and primary immunodeficiencies. It competes with AOM almost line-for-line in the immunoglobulin and chronic-disease specialty infusion space.
- BioPlus Specialty Pharmacy: BioPlus, part of CarelonRx (Elevance Health), is a specialty pharmacy focused on chronic and complex conditions, including IVIG, oncology, and biologic therapies. It is a direct competitor for immunoglobulin and chronic-disease specialty referrals.
- InfuSystem Holdings: InfuSystem provides infusion pump rental and ambulatory infusion therapy management services for chronic conditions, with overlap in the alternate-site/home infusion delivery model used by AOM. Comparable around ambulatory delivery of biologic and chronic-disease infusions.
- Amerita: Amerita is a specialty infusion provider offering home and ambulatory infusion services including IVIG and biologic therapies across multiple states. It is a regional-to-national direct competitor with a similar chronic-condition patient base and payor mix.
Broad incumbents
- Optum Infusion Pharmacy: Optum Infusion Pharmacy, part of UnitedHealth Group, provides home and suite-based infusion therapies across all 50 states. As a division of a large incumbent payor-provider, it competes broadly with AOM for payor contracts and physician referrals in the specialty infusion category.
- BrightSpring Health Services: BrightSpring is a large diversified home and community-based health services platform that includes specialty/home infusion and pharmacy services. It is a comparable incumbent in the broader alternate-site infusion market where AOM competes.
- Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy operates as part of a national retail/specialty pharmacy footprint offering home delivery of specialty medications including IVIG and biologics. It is an incumbent competitor for payor contracts and limited distribution drug networks where AOM also competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AOM Infusion social profiles
Digital presenceAOM Infusion compliance and trust
Trust signalCompliance4 records
AOM Infusion financial estimates
Financial estimateRevenue estimate
Valuation estimate
AOM Infusion leadership team
Management profileNumber of profiles
Profiles10 records
AOM Infusion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AOM Infusion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AOM Infusion
What does AOM Infusion do?
AOM Infusion is a specialty infusion pharmacy that administers infusion therapies—primarily intravenous and subcutaneous immunoglobulin (IVIG/SCIG), chronic inflammatory and biologic infusions, and specialized therapies—to patients with chronic neurologic, immunologic, and inflammatory conditions. Services are delivered either in the patient's home or in state-of-the-art ambulatory infusion suites in Brooklyn, NY and Arlington, TX, supported by insurance verification, prior authorization, and a Clinical Care Navigator Program for care coordination.
Is AOM Infusion a public or private company?
AOM Infusion is a private company. It is classified as private equity controlled and is currently operating.
When was AOM Infusion founded?
AOM Infusion was founded in 1995. It employs 51 to 100 people.
Where is AOM Infusion based?
AOM Infusion is headquartered in Fort Worth, United States, in the North America region.
How does AOM Infusion make money?
Three revenue lines are on record. Specialty Infusion Therapy Services are the primary driver. The others are specialty Pharmacy Dispensing and copay Assistance & Financial Support Services.
Who are AOM Infusion's main competitors?
Direct peers on record are Option Care Health, Coram CVS Specialty Infusion Services, Soleo Health, KabaFusion, BioPlus Specialty Pharmacy, InfuSystem Holdings and Amerita. Broad incumbents are Optum Infusion Pharmacy, BrightSpring Health Services and Walgreens Specialty Pharmacy.
Does AOM Infusion have an API?
No public API is recorded for AOM Infusion.
What industry is AOM Infusion in?
AOM Infusion's product category is Specialty Infusion Pharmacy. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLADAFAG, Home Infusion Therapy & IV Nursing Services. Its NAICS code is 621498 and its SIC code is 8093.